跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,748 条关于
“miR-483-5p”
全部
4,748
临床试验
3,466
药物
656
机构
93
资讯
533
去年
New-Onset Diabetes Emerges as Early Warning Signal for Pancreatic Cancer Detection
去年
HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles
去年
cGAS-STING Pathway Shows Dual Role in Breast Cancer Immunotherapy Response
2年前
Exosome-Based Cancer Therapy Advances: From Cell-Free Treatment to Targeted Drug Delivery
4个月前
Repurposed Drugs Show Promise for Treating Aggressive Infant Leukemia in Preclinical Studies
去年
CSF Biomarkers NfL, CHIT1, and miR-181b Evaluated for ALS Diagnosis and Prognosis
6个月前
FDA Issues First Formal Guidance on Form 483 Response Requirements for Drug Manufacturers
13天前
Cohance Lifescience Receives USFDA Form 483 With Four Observations at Telangana Formulation Plant
去年
USFDA Issues Form 483 with Two Observations for Dr. Reddy's New York API Facility
去年
Exosomes Emerge as Dual-Purpose Tools in Cancer: From Drug Resistance Mechanisms to Therapeutic Delivery Systems
第 1 页,共 54 页
上一页
下一页